Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

21.4%

3 terminated/withdrawn out of 14 trials

Success Rate

70.0%

-16.5% vs industry average

Late-Stage Pipeline

14%

2 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
8(80.0%)
Phase 4
2(20.0%)
10Total
N/A(8)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded